| Literature DB >> 27034403 |
Troy Noordenbos1, Iris Blijdorp1, Sijia Chen1, Jan Stap2, Erik Mul3, Juan D Cañete4, Erik Lubberts5, Nataliya Yeremenko1, Dominique Baeten6.
Abstract
IL-17A, a major proinflammatory cytokine, can be produced by a variety of leukocytes, but its exact cellular source in human inflammatory diseases remains incompletely understood. IL-17A protein is abundantly found in mast cells in human tissues, such as inflamed synovium, but surprisingly, mechanistic murine studies failed to demonstrate IL-17A production by mast cells. Here, we demonstrate that primary human tissue mast cells do not produce IL-17A themselves but actively capture exogenous IL-17A through receptor-mediated endocytosis. The exogenous IL-17A is stored in intracellular granules and can subsequently be released in a bioactive form. This novel mechanism confers to mast cells the capacity to steer IL-17A-mediated tissue inflammation by the rapid release of preformed cytokine. © Society for Leukocyte Biology.Entities:
Keywords: mRNA expression; spondyloarthritis; uptake
Mesh:
Substances:
Year: 2016 PMID: 27034403 DOI: 10.1189/jlb.3HI1215-542R
Source DB: PubMed Journal: J Leukoc Biol ISSN: 0741-5400 Impact factor: 4.962